Save up to 90% with the generic.
May be stored 30 days outside of refrigerator.
Information about Nplate (Romiplostim)
Nplate (generic name: romiplostim) is a medication used to treat certain types of blood disorders, specifically immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, leading to a low platelet count. Romiplostim is a synthetic peptide that stimulates the production of platelets by binding to and activating the thrombopoietin receptor on megakaryocytes, the cells in the bone marrow that produce platelets.
Nplate is typically used in patients with chronic ITP who have not responded adequately to other treatments, such as corticosteroids, immunoglobulins, or splenectomy.
Product Highlights
- A condition where the immune system destroys platelets, leading to an increased risk of bleeding. Nplate is used to increase platelet production and reduce the risk of bleeding in patients with chronic ITP who have had insufficient responses to other therapies.
- Nplate can also be used to treat pediatric patients with chronic ITP, where conventional therapies have failed or are inappropriate.
Key Ingredient
Key Benefits
- The main benefit of Nplate is its ability to increase the platelet count in patients with chronic ITP, which helps reduce the risk of bleeding and bruising.
- By promoting platelet production, it helps to lower the risk of serious bleeding events that are common in ITP patients with low platelet counts.
- Nplate is designed for long-term use, providing a treatment option for patients with chronic or persistent ITP that is resistant to other treatments.
- The drug is administered via a subcutaneous injection, typically once a week, allowing for flexible outpatient management.
Direction of Use
- Nplate is administered as a subcutaneous injection. The dosage and frequency depend on the patient’s platelet count and response to the medication.
- In general, Nplate is administered once a week. The healthcare provider will monitor the patient's platelet count and adjust the dose as necessary.
- The starting dose is typically 1 mcg/kg of body weight, and the dose can be adjusted to achieve the desired platelet count.
- Regular blood tests are required to monitor platelet count and avoid complications such as excessive platelet production.
Safety Concerns
- Long-term use of Nplate may increase the risk of bone marrow fibrosis, a condition where scar tissue forms in the bone marrow, potentially leading to reduced production of all blood cells. Regular monitoring is needed to detect this condition early.
- In some patients, an increase in platelet count may lead to the formation of blood clots (thrombosis), which can cause serious complications, including stroke or heart attack. Monitoring is critical, especially in patients with a history of clotting disorders.
- Frequent blood tests are required to assess platelet counts and to avoid over-correction, which can lead to thrombotic events or complications associated with excessive platelet counts.
- As with many injectable medications, there is a potential for local reactions at the injection site, such as redness, pain, or infection.
Avoid Nplate (Romiplostim) If
- Severe allergic reactions, such as anaphylaxis, could occur.
- If there is a history of bone marrow conditions other than ITP, such as bone marrow fibrosis or certain blood cancers, Nplate should be avoided due to the risk of worsening these conditions.
- Patients with active or recent history of thrombotic events (such as deep vein thrombosis or pulmonary embolism) should avoid Nplate due to the risk of thrombosis.
- Romiplostim is processed by the liver, so it should be used cautiously or avoided in patients with severe liver impairment.
- Nplate is classified as a Category C drug during pregnancy, meaning it may cause harm to a developing fetus. It should only be used during pregnancy if the potential benefit outweighs the risk. The safety during breastfeeding is not well established, so caution is advised.
This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.
